article Lentiviral vectors: the key to cancer treatments that CAR T-cell therapy cannot reach? 21 July 2021 | By Professor Christian Brechot (TheraVectys) Professor Christian Brechot explains why lentiviral vectors could serve as an effective tool for treating a wide range of cancers and could be used for vaccines.
news Activating STING enhances CAR T-cell activity in solid tumours, shows study 4 January 2021 | By Hannah Balfour (Drug Target Review) Researchers were able to eradicate breast cancer in mice when they combined CAR T cells with STING pathway agonists and immunotherapeutic antibodies.